I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 19 studies | 43% ± 14% | |
| GABAergic neuron | 3 studies | 31% ± 5% | |
| glutamatergic neuron | 3 studies | 40% ± 2% | |
| astrocyte | 3 studies | 27% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 19 studies | 43% ± 14% | |
| GABAergic neuron | 3 studies | 31% ± 5% | |
| glutamatergic neuron | 3 studies | 40% ± 2% | |
| astrocyte | 3 studies | 27% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 307.75 | 652 / 653 | 0% | 0 | 0 / 0 |
| kidney | 99% | 157.39 | 88 / 89 | 0% | 0 | 0 / 0 |
| ovary | 95% | 94.99 | 171 / 180 | 0% | 0 | 0 / 0 |
| brain | 95% | 135.56 | 2499 / 2642 | 0% | 0 | 0 / 0 |
| prostate | 93% | 79.71 | 228 / 245 | 0% | 0 | 0 / 0 |
| uterus | 93% | 104.03 | 158 / 170 | 0% | 0 | 0 / 0 |
| adrenal gland | 91% | 64.05 | 236 / 258 | 0% | 0 | 0 / 0 |
| pancreas | 90% | 48.01 | 294 / 328 | 0% | 0 | 0 / 0 |
| lung | 87% | 173.01 | 501 / 578 | 0% | 0 | 0 / 0 |
| breast | 73% | 81.22 | 336 / 459 | 0% | 0 | 0 / 0 |
| bladder | 71% | 28.62 | 15 / 21 | 0% | 0 | 0 / 0 |
| skin | 59% | 30.63 | 1069 / 1809 | 0% | 0 | 0 / 0 |
| heart | 55% | 26.51 | 475 / 861 | 0% | 0 | 0 / 0 |
| intestine | 52% | 23.01 | 506 / 966 | 0% | 0 | 0 / 0 |
| adipose | 47% | 21.79 | 566 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 44% | 17.68 | 593 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 40% | 17.16 | 144 / 359 | 0% | 0 | 0 / 0 |
| esophagus | 37% | 14.93 | 536 / 1445 | 0% | 0 | 0 / 0 |
| peripheral blood | 25% | 13.29 | 228 / 929 | 0% | 0 | 0 / 0 |
| spleen | 9% | 3.00 | 22 / 241 | 0% | 0 | 0 / 0 |
| muscle | 8% | 2.93 | 66 / 803 | 0% | 0 | 0 / 0 |
| liver | 1% | 0.31 | 2 / 226 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005930 | Cellular component | axoneme |
| GO_0005929 | Cellular component | cilium |
| GO_0005858 | Cellular component | axonemal dynein complex |
| GO_0048487 | Molecular function | beta-tubulin binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0008017 | Molecular function | microtubule binding |
| Gene name | DNAI7 |
| Protein name | Dynein axonemal intermediate chain 7 Dynein axonemal intermediate chain 7 (Cancer susceptibility candidate gene 1 protein) (Protein CASC1) (Cilia and flagella associated protein 94) (Lung adenoma susceptibility 1-like protein) (Protein phosphatase 1 regulatory subunit 54) |
| Synonyms | LAS1 CFAP94 PPP1R54 CASC1 |
| Description | FUNCTION: Via its association with the multisubunit axonemal dynein complex, is potentially involved in the regulation of cilia function. May also act as a cell cycle regulator. . |
| Accessions | ENST00000674567.1 Q6TDU7 ENST00000554347.1 A0A6Q8PG26 G3V2J3 ENST00000545133.5 [Q6TDU7-4] ENST00000395987.8 ENST00000395990.6 [Q6TDU7-2] B4DY27 ENST00000557684.6 ENST00000320267.13 [Q6TDU7-1] ENST00000556467.5 ENST00000354189.9 [Q6TDU7-3] F8W8F9 H0YJM7 ENST00000676236.1 G3V3G6 ENST00000554533.5 G3V333 ENST00000556006.6 |
